RP-G28: Clinical Trials

4 trials of RP-G28, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 2 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 32Completed 2
Phase 11Completed 1

Follow RP-G28: new trials by email Literature Review of RP-G28 trials Research Report on RP-G28

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
RP-G28, Placebos - Lactose Intolerance
Phase 3CompletedRitter Pharmaceuticals, Inc.5572018-06-262019-07-08
Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects
RP-G28 - Lactose Intolerance
Phase 1CompletedRitter Pharmaceuticals, Inc.142018-03-092018-08-08
Efficacy, Safety, and Tolerability Study of RP-G28 in Subjects With Lactose Intolerance
RP-G28, Placebo - Lactose Intolerance
Phase 2 / Phase 3CompletedRitter Pharmaceuticals, Inc.3772016-02-012018-04-04
Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose Intolerance
RP-G28 or placebo - Lactose Intolerance
Phase 2CompletedRitter Pharmaceuticals, Inc.612011-04-012011-12-08

Conditions studied

Lactose Intolerance (4)

Sponsors

Ritter Pharmaceuticals, Inc. (4)

Countries

United States (4)

Top investigators

Paul G Pearson, PhD (1)  ·  Sharron Gargosky, PhD (1)

Results publications

PMID 24330605, PMID 34365905